0001701108-17-000003.txt : 20170321
0001701108-17-000003.hdr.sgml : 20170321
20170321153635
ACCESSION NUMBER: 0001701108-17-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170321
DATE AS OF CHANGE: 20170321
EFFECTIVENESS DATE: 20170321
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spero Therapeutics, LLC
CENTRAL INDEX KEY: 0001701108
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-283010
FILM NUMBER: 17704081
BUSINESS ADDRESS:
STREET 1: 675 MASSACHUSETTS AVENUE
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-242-1600
MAIL ADDRESS:
STREET 1: 675 MASSACHUSETTS AVENUE
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
D
1
primary_doc.xml
X0707
D
LIVE
0001701108
Spero Therapeutics, LLC
675 MASSACHUSETTS AVENUE
14TH FLOOR
CAMBRIDGE
MA
MASSACHUSETTS
02139
857-242-1600
DELAWARE
None
None
Limited Liability Company
true
2013
Ankit
Mahadevia
c/o Spero Therapeutics, LLC
675 Massachusetts Avenue
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Director
Casper
Breum
c/o Spero Therapeutics, LLC
675 Massachusetts Avenue
Cambridge
MA
MASSACHUSETTS
02139
Director
Milind
Deshpande
c/o Spero Therapeutics, LLC
675 Massachusetts Avenue
Cambridge
MA
MASSACHUSETTS
02139
Director
Jean-Francois
Formela
c/o Spero Therapeutics, LLC
675 Massachusetts Avenue
Cambridge
MA
MASSACHUSETTS
02139
Director
Vikas
Goyal
c/o Spero Therapeutics, LLC
675 Massachusetts Avenue
Cambridge
MA
MASSACHUSETTS
02139
Director
Patrick
Vink
c/o Spero Therapeutics, LLC
675 Massachusetts Avenue
Cambridge
MA
MASSACHUSETTS
02139
Director
Reza
Halse
c/o Spero Therapeutics, LLC
675 Massachusetts Avenue
Cambridge
MA
MASSACHUSETTS
02139
Director
Stephen
Garbacz
c/o Spero Therapeutics, LLC
675 Massachusetts Avenue
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2017-03-07
false
true
false
0
43177051
43177051
0
false
11
0
0
0
false
Spero Therapeutics, LLC
/s/ Ankit Mahadevia, M.D.
Ankit Mahadevia, M.D.
President and Chief Executive Officer
2017-03-21